Table 5.
Risk for Clavien-Dindo score ≥ IIIb and 90-day mortality comparing patients with jejunostomy vs. no jejunostomy in patients with postoperative complications after esophagectomy for cancer
| No jejunostomy | Jejunostomy | P value | |
|---|---|---|---|
| Odds ratio (95% confidence interval)† | |||
| Clavien-Dindo score ≥ IIIb | |||
| Any complication | 1.0 (reference) | 1.09 (0.72–1.65) | 0.689 |
| Surgical complication | 1.0 (reference) | 1.07 (0.62–1.85) | 0.815 |
| Anastomotic leak | 1.0 (reference) | 0.19 (0.04–0.94) | 0.041 |
| Chylothorax | 1.0 (reference) | 0.67 (0.10–4.51) | 0.682 |
| Recurrent laryngeal nerve paralysis | 1.0 (reference) | 1.48 (0.29–7.51) | 0.633 |
| Non-surgical complication | 1.0 (reference) | 1.56 (0.92–2.63) | 0.099 |
| Cardiovascular complication | 1.0 (reference) | 2.24 (0.66–7.57) | 0.196 |
| Pulmonary embolism | 1.0 (reference) | 0.80 (0.15–4.12) | 0.788 |
| Pneumonia | 1.0 (reference) | 1.64 (0.71–3.79) | 0.248 |
| Septicemia | 1.0 (reference) | 0.82 (0.16–4.30) | 0.817 |
| 90-day mortality | |||
| Any complication | 1.0 (reference) | 0.85 (0.53–1.36) | 0.498 |
| Surgical complication | 1.0 (reference) | 0.71 (0.40–1.25) | 0.238 |
| Anastomotic leak | 1.0 (reference) | 0.53 (0.24–1.19) | 0.125 |
| Chylothorax | 1.0 (reference) | 0.21 (0.03–1.33) | 0.098 |
| Recurrent nerve paralysis | 1.0 (reference) | 0.59 (0.03–13.49) | 0.740 |
| Non-surgical complication | 1.0 (reference) | 0.76 (0.44–1.29) | 0.309 |
| Cardiovascular complication | 1.0 (reference) | 0.95 (0.31–2.88) | 0.922 |
| Pulmonary embolism | 1.0 (reference) | 0.86 (0.13–5.87) | 0.877 |
| Pneumonia | 1.0 (reference) | 0.68 (0.26–1.78) | 0.431 |
| Septicemia | 1.0 (reference) | 0.74 (0.26–2.09) | 0.572 |
†Adjusted for histological tumor type, clinical tumor stage, and American Society of Anesthesiologists Score